机构：[1]Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China[2]Beijing Key Laboratory and International Cooperation & Joint Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China[3]Department of Traditional Chinese Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China[4]The Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, China
National Natural Science
Foundation of China (81773891), Beijing Excellent Talent Project
(2018000021223TD09, DFL20190702), and the National Great New
Drugs Development Project of China (2017ZX09301-040).
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类|3 区医学
小类|3 区医学：研究与实验3 区药学
最新[2025]版：
大类|2 区医学
小类|2 区医学：研究与实验2 区药学
JCR分区：
出版当年[2018]版：
Q1PHARMACOLOGY & PHARMACYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版：
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构：[1]Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China[2]Beijing Key Laboratory and International Cooperation & Joint Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
通讯作者：
通讯机构：[1]Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China[2]Beijing Key Laboratory and International Cooperation & Joint Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing, China[*1]Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714)：
Yang Zhirui,Pan Guofeng,Zhang Luyong,et al.Deviating from clinical practice: Pharmacokinetics of Chinese materia medica faces a substantial challenge.[J].BIOMEDICINE & PHARMACOTHERAPY.2020,127:doi:10.1016/j.biopha.2020.110191.
APA：
Yang Zhirui,Pan Guofeng,Zhang Luyong&Yan Dan.(2020).Deviating from clinical practice: Pharmacokinetics of Chinese materia medica faces a substantial challenge..BIOMEDICINE & PHARMACOTHERAPY,127,
MLA：
Yang Zhirui,et al."Deviating from clinical practice: Pharmacokinetics of Chinese materia medica faces a substantial challenge.".BIOMEDICINE & PHARMACOTHERAPY 127.(2020)
